Teva Pharmaceutical Industries Limited (Tel Aviv: TEVA)
Petah Tikva, 49131, Israel Phone: +972-3-926-7267
Fax: +972-3-923-4050
http://www.tevapharm.com
Overview
Teva Pharmaceutical Industries is a big name in the no-name world of generic pharmaceuticals. The company makes hundreds of generic versions of brand-name antibiotics, heart drugs, heartburn medications, and more. Subsidiary Teva Pharmaceuticals USA generics product line include equivalents of such blockbusters as antidepressant Prozac and osteoporosis drug Fosamax. The company, Israel's top drugmaker, also develops and manufactures proprietary branded drugs, including multiple sclerosis treatment Copaxone, Parkinson's disease treatment Azilect, and a portfolio of women's health treatments. Its active pharmaceutical ingredient (API) division makes drug components for Teva and other manufacturers.
Sample Overview & HistoryKey Numbers from Hoover's UK
Key financials for Teva Pharmaceutical Industries Limited (Tel Aviv: TEVA)
| Company Type | Public (Tel Aviv: TEVA; NASDAQ: TEVA [ADR]) |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | £10,420.6 |
| 1-Year Sales Growth | 16.0% |
| 2010 Net Income (mil.) | £2,153.2 |
| 1-Year Net Income Growth | 66.5% |
| 2010 Employees | 39,660 |
| 1-Year Employee Growth | 13.0% |
Key People from Hoover's UK
Key people and executives for Teva Pharmaceutical Industries Limited (Tel Aviv: TEVA)
| Chairman | Phillip Frost (Subscribers see complete biographies -- view sample)
|
|---|---|
| President and CEO | Shlomo Yanai |
| CFO | Eyal Desheh |
Top Competitors from Hoover's UK
Top competitors of Teva Pharmaceutical Industries Limited (Tel Aviv: TEVA)
There are 22 competitors for Teva; see more.Industry Information from Hoover's UK
First Research Industry Profiles Extensive Industry Intelligence
Hoover's Industries
-
Pharmaceuticals
- Generic Drugs(primary)
Subsidiaries/Affiliates Covered By Hoover's UK
Subsidiaries/affiliates of Teva Pharmaceutical Industries Limited (Tel Aviv: TEVA)
Rankings from Hoover's UK
See how Teva Pharmaceutical Industries Limited (Tel Aviv: TEVA) ranks in standard industry listings such as Fortune 500, S&P 500, and Dow Jones
- #169 in FT Global 500 (June 2011)

